ATE250603T1 - 1,8-naphthalimid imidazo(4,5,1-de)acridone mit antitumorwirkung - Google Patents

1,8-naphthalimid imidazo(4,5,1-de)acridone mit antitumorwirkung

Info

Publication number
ATE250603T1
ATE250603T1 AT01914696T AT01914696T ATE250603T1 AT E250603 T1 ATE250603 T1 AT E250603T1 AT 01914696 T AT01914696 T AT 01914696T AT 01914696 T AT01914696 T AT 01914696T AT E250603 T1 ATE250603 T1 AT E250603T1
Authority
AT
Austria
Prior art keywords
compounds
acridone
naphthalimide
imidazo
antitumor effect
Prior art date
Application number
AT01914696T
Other languages
English (en)
Inventor
Wieslaw M Cholody
Teresa Kosakowska-Cholody
Christopher J Michejda
Original Assignee
Us Gov Health & Human Serv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Us Gov Health & Human Serv filed Critical Us Gov Health & Human Serv
Application granted granted Critical
Publication of ATE250603T1 publication Critical patent/ATE250603T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/06—Peri-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT01914696T 2000-03-07 2001-03-05 1,8-naphthalimid imidazo(4,5,1-de)acridone mit antitumorwirkung ATE250603T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US18799100P 2000-03-07 2000-03-07
PCT/US2001/007087 WO2001066545A2 (en) 2000-03-07 2001-03-05 1,8-NAPHTHALIMIDE IMIDAZO[4,5,1-de]ACRIDONES WITH ANTI-TUMOR ACTIVITY

Publications (1)

Publication Number Publication Date
ATE250603T1 true ATE250603T1 (de) 2003-10-15

Family

ID=22691331

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01914696T ATE250603T1 (de) 2000-03-07 2001-03-05 1,8-naphthalimid imidazo(4,5,1-de)acridone mit antitumorwirkung

Country Status (8)

Country Link
US (1) US6664263B2 (de)
EP (1) EP1265898B1 (de)
JP (1) JP2003525940A (de)
AT (1) ATE250603T1 (de)
AU (2) AU2001240054B2 (de)
CA (1) CA2402446C (de)
DE (1) DE60100855T2 (de)
WO (1) WO2001066545A2 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1519939E (pt) 2002-07-05 2010-02-10 Targacept Inc Compostos n-arildiazaspirocíclicos e métodos para a sua preparação e utilização
CA2586320A1 (en) * 2003-11-05 2005-05-19 Photobiomed Corporation Bonding tissues and cross-linking proteins with naphthalimide compounds
WO2006003670A1 (en) * 2004-06-30 2006-01-12 Council Of Scientific And Industrial Research Pyrrolo[2,1-c][1,4]benzodiazepine-napthalimide conjugates linked through piperazine moiety and process for preparation thereof
US6979684B1 (en) 2004-06-30 2005-12-27 Council Of Scientific And Industrial Research Pyrrolo[2,1-c][1,4]benzodiazepine-napthalimide conjugates linked through piperazine moiety and process for preparation thereof
US20080108641A1 (en) * 2006-02-08 2008-05-08 Ajami Alfred M Compounds for treating inflammatory disorders, demyelinating disdorders and cancers
WO2007092436A2 (en) * 2006-02-08 2007-08-16 Xanthus Pharmaceuticals, Inc. Compounds for treating inflammatory disorders, demyelinating disorders and cancers
CN100364536C (zh) * 2006-03-03 2008-01-30 大连理工大学 甲基异硫脲阳离子作为连接基的脱氧核糖核酸双嵌入剂
WO2008016660A2 (en) * 2006-08-02 2008-02-07 Xanthus Pharmaceuticals, Inc. Imidazoacridine compounds for treating leukemias
WO2008016661A2 (en) * 2006-08-02 2008-02-07 Xanthus Pharmaceuticals, Inc. Morpholino compounds for treating inflammatory and demyelinating diseases and cancers
US20100016300A1 (en) * 2006-08-02 2010-01-21 Ajami Alfred M Imidazoacridine Compounds for Treating FLT3-Mediated Disorders
CN101610759A (zh) * 2006-11-07 2009-12-23 美国政府卫生与公共服务部 由跨膜肽组成的自组装纳米颗粒及其用于特异性肿瘤内递送抗癌药物的应用
CN112898301B (zh) * 2021-01-29 2022-03-08 河南大学 一种萘酰亚胺吲哚杂环化合物、其制备方法及应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9104548D0 (en) * 1991-03-05 1991-04-17 Cholody Wienlaw M Antineoplastic modified imidazoacridines
IL110460A (en) 1993-08-18 2001-01-11 Basf Ag Bis-naphthalimides, their preparation and pharmaceutical compositions containing them
PT892801E (pt) 1996-04-12 2002-06-28 Us Gov Health & Human Serv Compostos derivados de acridona uteis como agentes antineoplasicos e antiretrovirais

Also Published As

Publication number Publication date
US20030203916A1 (en) 2003-10-30
CA2402446C (en) 2011-05-17
CA2402446A1 (en) 2001-09-13
AU4005401A (en) 2001-09-17
DE60100855D1 (de) 2003-10-30
EP1265898A2 (de) 2002-12-18
US6664263B2 (en) 2003-12-16
DE60100855T2 (de) 2004-07-15
WO2001066545A3 (en) 2002-02-28
AU2001240054B2 (en) 2005-08-11
WO2001066545A2 (en) 2001-09-13
JP2003525940A (ja) 2003-09-02
EP1265898B1 (de) 2003-09-24

Similar Documents

Publication Publication Date Title
GEP20247679B (en) Bicyclic heterocycles as fgfr inhibitors
WO2018141002A3 (en) DERIVATIVES OF N-CYCLOALKYL/HETEROCYCLOALKYL-4-(IMIDAZO [1,2-a]PYRIDINE)PYRIMIDIN-2-AMINE AS THERAPEUTIC AGENTS
AU7779900A (en) Trifluoromethyl-substituted spirocyclic ketoenols
EA200100954A1 (ru) Производные камптотецина, обладающие противоопухолевой активностью
PE20130012A1 (es) Derivados de pirazol como inhibidores de jak
UY27834A1 (es) Compuestos de amidas de acido 3-amino-tieno(2,3-b) piiridino-2-carboxilico sustituido y procedimientos para prepararlos y sus usos.
UY25344A1 (es) Procedimiento para la preparacion de derivados de la tienopirimidina y de la tienopiridina utiles como agentes anticancerigenos
EA201691294A2 (ru) ГЕТЕРОАРИЛЗАМЕЩЕННЫЕ ПИРРОЛО[2,3-b]ПИРИДИНЫ И ПИРРОЛО[2,3-b]ПИРИМИДИНЫ В КАЧЕСТВЕ ИНГИБИТОРОВ ЯНУС-КИНАЗЫ
GB0119249D0 (en) Organic compounds
MXPA05012592A (es) Nuevas piridopirazinas y uso de las mismas como inhibidores de cinasa.
BRPI0412993A (pt) inibidores da atividade da akt
UA29466C2 (uk) Фармацевтична композиція з антипухлинною активністю
CR6577A (es) Inhibidores triciclicos de poli(adp-ribosa) polimerasas
MX2025002794A (es) Compuestos citotoxicos de imidazo[1,2-a]piridina y su uso en terapia
DE60100855D1 (de) 1,8-naphthalimid imidazo[4,5,1-de]acridone mit antitumorwirkung
MX2011008452A (es) Derivados de triazolo [4,3-b] piridazina y sus usos para el cancer de prostata.
MY150747A (en) Pyrido[2,3-d] pyrimidin-7-one compounds as inhibitors of pi3k-alpha for the treatment of cancer
TW200616615A (en) Compounds and methods for the treatment of cancer
DE60004027D1 (de) Organische-arsenverbindungen
NO20080418L (no) Pyrido[2,3-D]pyrimidiriderivater, fremgangsmate for fremstilling derav og terapeutisk anvendelse av samme
ECSP045477A (es) COMPUESTOS DE AMIDAS DE ÁCIDO3-AMINO-TIENO[2,3-b]PIRIDINO-2-CARBOXÍLICO SUSTITUIDOY PROCEDIMIENTOS PARA PREPARARLOS Y SUS USOS.
IL138352A0 (en) Fungicidal 6-(2-halo-4-alkoxyphenyl) triazolopyrimidines
IS5588A (is) Æxliseyðandi miðlar
WO2007019308A3 (en) Illudin analogs useful as anticancer agents
CO5080802A1 (es) Nuevos compuestos heterociclicos inhibidores de la fosfodiesteresa iv y su formulacion y uso como productos farmaceuticos

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties